Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Abraham Palache

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Human Influenza

Procedures

Concepts & Ideas

Immunologic Dose-Response Relationship

Phenomena

Disease Outbreaks

Anatomy

Cell Line

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
13
Beyer, Walter
7
van Scharrenburg, GJ
6
Osterhaus, Albert
6
Brands, R
5
de Bruijn, Iris
4
Nauta, Jozef
4
Rimmelzwaan, Guus
4
Wilschut, Jan
3
Osterhaus, A D M E
3
de Jong, Jan
3
Gerez, Lisya
2
Holtrop, Marijke
2
Huckriede, Anke
2
Bungener, Laura
2
Claas, Eric

Sign-in to see all Coauthors

Publications

TOP 3
de Bruijn I A; Nauta J; Gerez L; Palache A M
The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad in elderly subjects.
Huckriede Anke; Bungener Laura; Stegmann Toon; Daemen Toos; Medema Jeroen; Palache Abraham M; Wilschut Jan
The virosome concept for influenza vaccines.
de Bruijn I A; Nauta J; Cramer W C M; Gerez L; Palache A M
Clinical experience with inactivated, virosomal influenza vaccine.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Abraham Palache (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2006: de Bruijn I A; Nauta J; Gerez L; Palache A M
The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad in elderly subjects.
Vaccine 2006;24(44-46):6629-31.
2005: Huckriede Anke; Bungener Laura; Stegmann Toon; Daemen Toos; Medema Jeroen; Palache Abraham M; Wilschut Jan
The virosome concept for influenza vaccines.
Vaccine 2005;23 Suppl 1():S26-38.
2005: de Bruijn I A; Nauta J; Cramer W C M; Gerez L; Palache A M
Clinical experience with inactivated, virosomal influenza vaccine.
Vaccine 2005;23 Suppl 1():S39-49.
2004: de Bruijn I A; Nauta J; Gerez L; Palache A M
Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers.
Virus research 2004;103(1-2):139-45.
2004: Beyer W E P; Palache A M; Lüchters G; Nauta J; Osterhaus A D M E
Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?
Virus research 2004;103(1-2):125-32.
2004: Medema Jeroen K; Zoellner York F; Ryan James; Palache Abraham M
Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply.
Virus research 2004;103(1-2):9-15.
2003: Stephenson Iain; Nicholson Karl G; Glück Reinhardt; Mischler Robert; Newman Robert W; Palache Abraham M; Verlander Neville Q; Warburton Fiona; Wood John M; Zambon Maria C
Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial.
Lancet 2003;362(9400):1959-66.
2003: Huckriede Anke; Bungener Laura; ter Veer Wouter; Holtrop Marijke; Daemen Toos; Palache Abraham M; Wilschut Jan
Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity.
Vaccine 2003;21(9-10):925-31.
2003: de Jong J C; Palache A M; Beyer W E P; Rimmelzwaan G F; Boon A C M; Osterhaus A D M E
Haemagglutination-inhibiting antibody to influenza virus.
Developments in biologicals 2003;115():63-73.
2002: Beyer W E P; Palache A M; de Jong J C; Osterhaus A D M E
Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
Vaccine 2002;20(9-10):1340-53.
2001: Haan L; Verweij W R; Holtrop M; Brands R; van Scharrenburg G J; Palache A M; Agsteribbe E; Wilschut J
Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity.
Vaccine 2001;19(20-22):2898-907.
2000: de Jong J C; Beyer W E; Palache A M; Rimmelzwaan G F; Osterhaus A D
Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
Journal of medical virology 2000;61(1):94-9.
1999: Voeten J T; Brands R; Palache A M; van Scharrenburg G J; Rimmelzwaan G F; Osterhaus A D; Claas E C
Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium.
Vaccine 1999;17(15-16):1942-50.
1999: Beyer W E; de Bruijn I A; Palache A M; Westendorp R G; Osterhaus A D
Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies.
Archives of internal medicine 1999;159(2):182-8.
1999: Palache A M; Scheepers H S; de Regt V; van Ewijk P; Baljet M; Brands R; van Scharrenburg G J
Safety, reactogenicity and immunogenicity of Madin Darby Canine Kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies.
Developments in biological standardization 1999;98():115-25; discussion 133-4.
1999: Brands R; Visser J; Medema J; Palache A M; van Scharrenburg G J
Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.
Developments in biological standardization 1999;98():93-100; discussion 111.
1999: Voeten J T; Claas E C; Brands R; Palache A M; van Scharrenburg G J; Rimmelzwaan G F; Osterhaus A D
Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells.
Developments in biological standardization 1999;98():77-87; discussion 89-90.
1998: Beyer W E; de Bruijn I A; Palache A M; Westendorp R G; Osterhaus A D
The plea against annual influenza vaccination? 'The Hoskins' Paradox' revisited.
Vaccine 1998;16(20):1929-32.
1998: Beyer W E; Palache A M; Osterhaus A D
Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature.
Clinical drug investigation 1998;15(1):1-12.
1997: Palache A M
Influenza vaccines. A reappraisal of their use.
Drugs 1997;54(6):841-56.
1997: Palache A M; Brands R; van Scharrenburg G J
Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs.
The Journal of infectious diseases 1997;176 Suppl 1():S20-3.
1996: Beyer W E; Palache A M; Sprenger M J; Hendriksen E; Tukker J J; Darioli R; van der Water G L; Masurel N; Osterhaus A D
Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.
Vaccine 1996;14(14):1331-9.
1996: Palache A M; Beyer W E; Hendriksen E; Gerez L; Aston R; Ledger P W; de Regt V; Kerstens R; Rothbarth P H; Osterhaus A D
Adjuvancy and reactogenicity of N-acetylglucosaminyl-N-acetylmuramyl-dipeptide (GMDP) orally administered just prior to trivalent influenza subunit vaccine. A double-blind placebo-controlled study in nursing home residents.
Vaccine 1996;14(14):1327-30.
1996: Beyer W E; Palache A M; Kerstens R; Masurel N
Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(1):65-70.
1995: de Haan A; Geerligs H J; Huchshorn J P; van Scharrenburg G J; Palache A M; Wilschut J
Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes.
Vaccine 1995;13(2):155-62.
1993: Palache A M; Beyer W E; Sprenger M J; Masurel N; de Jonge S; Vardy A; Charpentier B; Noury J; van Beek W C; Borst R J
Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers.
Vaccine 1993;11(1):3-9.
1993: Remarque E J; van Beek W C; Ligthart G J; Borst R J; Nagelkerken L; Palache A M; Sprenger M J; Masurel N
Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines.
Vaccine 1993;11(6):649-54.
1993: Palache A M; Beyer W E; Lüchters G; Völker R; Sprenger M J; Masurel N
Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature.
Vaccine 1993;11(9):892-908.
1989: Beyer W E; Palache A M; Baljet M; Masurel N
Antibody induction by influenza vaccines in the elderly: a review of the literature.
Vaccine 1989;7(5):385-94.

Sign-in to see more